Brian Varnum - 02 Aug 2021 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
CEO, Director
Signature
/s/ Brian Varnum
Issuer symbol
ARMP
Transactions as of
02 Aug 2021
Transactions value $
$0
Form type
4
Filing time
03 Aug 2021, 17:23:56 UTC
Next filing
15 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Option (Right to Buy) Award $0 +125K $0.00 125K 02 Aug 2021 Common Stock 125K $3.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to twenty-five percent (25%) of the underlying shares of common stock on each of the first, second, third and fourth annual anniversaries of the date of grant.